Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Revenue Recognition - Disaggregation of Revenue (Details)

v3.22.0.1
Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue $ 484,329 $ 444,448 $ 408,830
Clinical Services      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue 404,172 382,337 361,161
Pharma Services      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue 80,157 62,111 47,669
Client direct billing | Clinical Services      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue 252,617 240,535 212,703
Commercial insurance | Clinical Services      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue 78,773 76,550 83,107
Medicare and other government | Clinical Services      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue 72,010 64,776 64,745
Self-pay | Clinical Services      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue $ 772 $ 476 $ 606